Do Psychedelic Drugs Hold Key To Medicinal Cures?
Since the discovery of LSD in 1940, there has been intense interest in pursuing psychedelic drugs as remedies for physical and psychological conditions. It has been a challenge for anyone to obtain the rights to use psychedelics, entirely illegal drugs, for medical study. In the few cases where scientists have been successful in obtaining the go-ahead to study, there is some promise.
For example, Ketamine, a painkiller that can be abused in order to hallucinate, has been shown to alleviate chronic depression in up to 45% of patients. It’s less restricted than other drugs, which means we may see it enter clinical practice first.
LSD-assisted therapy has for more than four decades now been shown to alleviate anxiety in terminally ill patients and can also be a treatment for alcoholism. Psilocybin and MDMA are similar in that they can relieve anxiety and also treat some of the symptoms of OCD and PTSD. PTSD is a particularly important area of research due to the number of soldiers inflicted with the disorder from their service during the wars in the middle east.
There’s a lot of potential in this line of research, and many believe that it’s time we open up these Schedule I drugs and allow a more thorough study of them.
The DEA and USDA maintain that there isn’t enough research present today to justify a recategorization of these drugs. This stance of course limits the ability for scientists to do more research on the drugs. Clearly there is a good reason for the government to keep up their war on drugs at the expense of medical breakthroughs.
What’s your take on this? Have you or someone you know ever benefited from psychedelics? Let us know in the comments below!